Milacron Holdings Corp. (Form: 10-Q, Received: 05/02/2019 13:38:34)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________

Form 10-Q

________________



ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019



o	TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____.

Commission File Number 001-37458

___________________________

Milacron Holdings Corp.

(Exact name of registrant as specified in its charter)

___________________________



Delaware		80-0798640
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification Number)
	10200 Alliance Road, Suite 200
	Cincinnati, Ohio 45242
(Address of principal executive offices, including zip code)
	(513) 487-5000
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.



Large accelerated filer ý	Accelerated filer ¨	Non-accelerated filer ¨	Smaller reporting company ¨	Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financing accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No ý

At March 31, 2019 , there were 70,501,787 common shares, $0.01 par value per share, outstanding.

Milacron Holdings Corp.

Quarterly Report on Form 10-Q

For the Period Ended March 31, 2019

TABLE OF CONTENTS



		Page

Cautionary Note Regarding Forward-Looking Statements

	PART I. FINANCIAL INFORMATION
ITEM 1.	Financial Statements
	Condensed Consolidated Balance Sheets - March 31, 2019 (Unaudited) and December 31, 2018	4
	Condensed Consolidated Statements of Operations - Three Months Ended March 31, 2019 and 2018 (Unaudited)	5
	Condensed Consolidated Statements of Comprehensive Income (Loss) - Three Months Ended March 31, 2019 and 2018 (Unaudited)	6
	Condensed Consolidated Statements of Shareholders' Equity - Three Months Ended March 31, 2019 and 2018 (Unaudited)	7
	Condensed Consolidated Statements of Cash Flows - Three Months Ended March 31, 2019 and 2018 (Unaudited)	8
	Notes to Condensed Consolidated Financial Statements (Unaudited)	9

ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	38
ITEM 4.	Controls and Procedures	40

	PART II. OTHER INFORMATION
ITEM 1.	Legal Proceedings	40
ITEM 1A.	Risk Factors	40
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	40
ITEM 3.	Defaults Upon Senior Securities	41
ITEM 4.	Mine Safety Disclosures	41
ITEM 5.	Other Information	41
ITEM 6.	Exhibits	42

SIGNATURE		43

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are subject to risks and uncertainties. All statements other than statements of historical fact or relating to present facts or current conditions contained in this Quarterly Report on Form 10-Q are forward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “should,” “can have,” “likely” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. Examples of forward-looking statements include, but are not limited to statements we make regarding (1) our belief that our cash and cash equivalents, cash flow from operations and borrowings under our asset-based revolving credit facility and other foreign lines of credit will provide us adequate cash to fund the operating needs, working capital, capital expenditure, debt service and other requirements for our business for the foreseeable future; (2) estimated capital expenditures for future periods; and (3) estimated cost savings and opportunities to drive margin improvements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on assumptions that we have made in light of our industry experience and our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances. As you read this Quarterly Report on Form 10-Q, you should understand that these statements are not guarantees of performance or results. They involve risks, uncertainties (many of which are beyond our control) and assumptions. Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect our actual operating and financial performance and cause our performance to differ materially from the performance anticipated in the forward-looking statements, including the risk factors discussed in Item 1A. Risk Factors included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the Securities and Exchange Commission ("SEC") on February 28, 2019. There may be other factors that may cause our actual results to differ materially from the forward-looking statements.

Should one or more of these risks or uncertainties materialize, or should any of these assumptions prove incorrect, our actual operating and financial performance may vary in material respects from the performance projected in these forward-looking statements. We caution you therefore against relying on these forward-looking statements.

Any forward-looking statement made by us in this Quarterly Report on Form 10-Q speaks only as of the date on which we make it. Factors or events that could cause our actual operating and financial performance to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS



	March 31, 2019
	(Unaudited)			December 31, 2018
	(in millions, except share data)
Assets
Current assets:
Cash and cash equivalents	$	150.0		$	184.0
Accounts receivable, net	149.6			146.3
Inventories, net:
Raw materials	80.6			73.2
Work-in-process	52.1			46.7
Finished products	120.4			118.6
Total inventories, net	253.1			238.5
Prepaid and other current assets	47.5			49.1
Current assets held for sale	65.0			36.9
Total current assets	665.2			654.8
Property and equipment, net	208.2			215.7
Operating lease right-of-use assets	34.2			—
Goodwill	520.3			513.2
Intangible assets, net	291.0			292.7
Other noncurrent assets	25.4			29.1
Noncurrent assets held for sale	—			27.0
Total assets	$	1,744.3		$	1,732.5
Liabilities and shareholders’ equity
Current liabilities:
Short-term borrowings	$	3.1		$	5.8
Accounts payable	106.3			116.8
Advanced billings and deposits	43.6			38.9
Accrued salaries, wages and other compensation	22.1			24.0
Other current liabilities	67.1			66.0
Current liabilities held for sale	15.8			14.9
Total current liabilities	258.0			266.4
Long-term debt	824.3			829.0
Deferred income tax liabilities	57.5			57.5
Accrued pension liabilities	27.2			27.6
Operating lease liabilities	26.4			—
Other noncurrent accrued liabilities	13.9			25.2
Total liabilities	1,207.3			1,205.7
Shareholders’ equity:
Preferred stock - $0.01 par value, 50,000,000 shares authorized, none outstanding	—			—
Common stock - $0.01 par value, 500,000,000 shares authorized; 71,044,661 and 70,726,800 shares
issued as of March 31, 2019 and December 31, 2018, respectively, and 70,501,787 and
70,454,138 shares outstanding as of March 31, 2019 and December 31, 2018, respectively	0.7			0.7
Capital in excess of par value	698.1			693.5
Treasury stock - at cost; 542,874 and 272,662 shares as of March 31, 2019 and December 31, 2018,
respectively	(7.2		)	(3.5		)
Retained deficit	(29.3		)	(29.0		)
Accumulated other comprehensive loss	(125.3		)	(134.9		)
Total shareholders’ equity	537.0			526.8
Total liabilities and shareholders’ equity	$	1,744.3		$	1,732.5

See accompanying notes.

MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)



		Three Months Ended March 31,
		2019			2018
	(in millions, except per share data)
Net sales		$	248.7		$	288.8
Cost of sales		163.9			188.9
Manufacturing margins		84.8			99.9
Operating expenses:
Selling, general and administrative expenses		54.1			62.1
Amortization expense		5.6			6.3
(Gain) loss on currency translation		(0.7		)	0.7
Other (income) expense, net		(0.1		)	7.6
Total operating expenses		58.9			76.7
Operating earnings		25.9			23.2
Interest expense, net		9.5			10.7
Loss on debt extinguishment		—			0.3
Other non-operating expenses		0.2			0.3
Earnings from continuing operations before income taxes		16.2			11.9
Income tax expense		7.0			5.4
Net earnings from continuing operations		9.2			6.5
Loss from discontinued operations (net of income taxes)		(10.0		)	(0.6		)
Net (loss) earnings		$	(0.8	)	$	5.9

Earnings (loss) per share:
Basic:
Net earnings from continuing operations		$	0.13		$	0.09
Loss from discontinued operations		(0.14		)	(0.01		)
Net (loss) earnings		$	(0.01	)	$	0.08

Diluted:
Net earnings from continuing operations		$	0.13		$	0.09
Loss from discontinued operations		(0.14		)	(0.01		)
Net (loss) earnings		$	(0.01	)	$	0.08

See accompanying notes.

MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)



		Three Months Ended March 31,
		2019			2018
	(in millions)
Net (loss) earnings		$	(0.8	)	$	5.9
Other comprehensive income (loss), net of tax:
Foreign currency translation gain		11.1			26.6
Unrecognized post-retirement plan gain		0.1			—
Unrealized (loss) gain on hedging activities		(1.6		)	4.4
Total other comprehensive income, net of tax		9.6			31.0
Comprehensive income		$	8.8		$	36.9

See accompanying notes.

MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(Unaudited)



	Common Stock (Shares)	Common Stock		Capital In Excess of Par Value		Treasury Stock (Shares)		Treasury Stock			Retained Deficit			Accumulated Other Comprehensive Loss			Totals
	(in millions, except share data)
Balance at December 31, 2017	69,644,918	$	0.7	$	675.9	—		$	—		$	(70.5	)	$	(85.4	)	$	520.7
Stock-based compensation activity	732,789	—		5.5		—		—			—			—			5.5
Net earnings	—	—		—		—		—			5.9			—			5.9
Other comprehensive income, net of tax	—	—		—		—		—			—			31.0			31.0
Balance at March 31, 2018	70,377,707	$	0.7	$	681.4	—		$	—		$	(64.6	)	$	(54.4	)	$	563.1

Balance at December 31, 2018	70,726,800	$	0.7	$	693.5	(272,662	)	$	(3.5	)	$	(29.0	)	$	(134.9	)	$	526.8
Adjustment to adopt new lease accounting standard	—	—		—		—		—			0.5			—			0.5
Stock-based compensation activity	317,861	—		4.6		—		—			—			—			4.6
Purchase of treasury stock	—	—		—		(270,212	)	(3.7		)	—			—			(3.7		)
Net loss	—	—		—		—		—			(0.8		)	—			(0.8		)
Other comprehensive income, net of tax	—	—		—		—		—			—			9.6			9.6
Balance at March 31, 2019	71,044,661	$	0.7	$	698.1	(542,874	)	$	(7.2	)	$	(29.3	)	$	(125.3	)	$	537.0

See accompanying notes.

MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)



	Three Months Ended March 31,
	2019			2018
	(in millions)
Operating activities from continuing operations
Net (loss) earnings	$	(0.8	)	$	5.9
Loss from discontinued operations (net of income taxes)	10.0			0.6
Adjustments to reconcile net (loss) earnings from continuing operations to net cash (used in) provided by operating activities from continuing operations:
Depreciation and amortization	11.9			13.2
Unrealized (gain) loss on currency translation of intercompany advances	(1.7		)	0.2
Amortization of deferred financing costs	0.6			0.7
Loss on debt extinguishment	—			0.3
Non-cash stock-based compensation expense	3.3			2.7
Deferred income taxes	(1.2		)	1.1
Changes in assets and liabilities:
Accounts receivable	(3.0		)	3.2
Inventories	(13.7		)	(13.0		)
Prepaid and other current assets	1.1			(4.6		)
Accounts payable	(8.8		)	(1.9		)
Advanced billings and deposits	4.5			11.8
Other current liabilities	(7.2		)	(9.1		)
Other noncurrent assets	0.9			0.7
Other noncurrent accrued liabilities	(0.5		)	(0.1		)
Net cash (used in) provided by operating activities from continuing operations	(4.6		)	11.7
Investing activities from continuing operations
Purchases of property and equipment	(18.0		)	(7.2		)
Proceeds from disposals of property and equipment	0.2			8.0
Net cash (used in) provided by investing activities from continuing operations	(17.8		)	0.8
Financing activities from continuing operations
Payments on long-term debt and capital lease obligations (original maturities longer than 90 days)	(5.0		)	(25.0		)
Net decrease in short-term borrowings (original maturities of 90 days or less)	(2.8		)	(0.1		)
Proceeds from exercise of stock options	1.3			2.8
Purchase of treasury stock	(3.7		)	—
Net cash used in financing activities from continuing operations	(10.2		)	(22.3		)
Cash used in continuing operations	(32.6		)	(9.8		)
Cash used in discontinued operations
Operating cash flows	(2.6		)	(4.1		)
Investing cash flows	(0.2		)	(0.1		)
Total cash used in discontinued operations	(2.8		)	(4.2		)
Effect of exchange rate changes on cash	1.4			2.8
Decrease in cash and cash equivalents	(34.0		)	(11.2		)
Cash and cash equivalents at beginning of period	184.0			187.9
Cash and cash equivalents at end of period	$	150.0		$	176.7

See accompanying notes

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

As of March 31, 2019 and December 31, 2018 and for the

Three Months Ended March 31, 2019 and 2018

1. Background and Basis of Presentation

Milacron Holdings Corp. (the "Company" or "Milacron") is a global leader in the manufacture, distribution, and service of highly engineered and customized systems used in the plastic technology and processing industry. The Company has a full-line product portfolio that includes hot runner systems, injection molding, blow molding and extrusion equipment and produces process control systems, mold bases and components and maintenance, repair and operating ("MRO") supplies for plastic processing equipment and fluid technology. The Company operates throughout the world and is headquartered in Cincinnati, Ohio.

The accompanying unaudited Condensed Consolidated Financial Statements of the Company have been prepared in accordance with generally accepted accounting principles for interim financial information and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by United States generally accepted accounting principles ("U.S. GAAP") for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the Condensed Consolidated Financial Statements for the interim periods. The interim period results are not necessarily indicative of the results to be expected for the full year. These interim Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and related notes for the fiscal year ended December 31, 2018 included in the Company’s Annual Report on Form 10-K filed with the SEC on February 28, 2019.

Recently Adopted Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 establishes a right-of-use ("ROU") model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than twelve months. Leases will be either classified as finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 also requires significant additional disclosures about the amount, timing and uncertainty of cash flows from leases. The Company adopted ASU 2016-02 on January 1, 2019 using a modified retrospective method and the impact of that adoption is materially consistent with the balances recorded within the Company's Condensed Consolidated Balance Sheets as of March 31, 2019. There was no material impact to the Company's consolidated net (loss) earnings, shareholders' equity or cash flows. Under the modified retrospective approach, the Company did not adjust its comparative period financial information or make new lease disclosures for periods before the effective date. As permitted under ASU 2016-02, the Company also elected the package of practical expedients and will carry forward the assessment of whether contracts contain or are leases and the classification of leases.

In February 2018, the FASB issued ASU No. 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) (ASU 2018-02). ASU 2018-02 allows for an entity to elect to reclassify from accumulated other comprehensive income (loss) to retained earnings the income tax effects on items resulting from what is commonly referred to as the U.S. Tax Cuts and Jobs Act of 2017 (the "Tax Act"). ASU 2018-02 is effective for fiscal years beginning after December 15, 2018 with early adoption permitted, including interim periods within those years. The Company has elected to not reclassify the stranded income tax effects of the Tax Act from accumulated other comprehensive income (loss) to retained earnings.

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

2. Background and Basis of Presentation (continued)

Lease Accounting Policy

The Company determines if an arrangement contains a lease at inception and recognizes ROU assets and liabilities associated with leases based on the present value of the future minimum lease payments over the lease term at the later of the commencement date of the lease or January 1, 2019 (the implementation date of ASU 2016-02). The Company uses its incremental borrowing rate at the commencement date in determining the present value of future payments for leases where the implicit rate cannot be readily determined. Lease terms reflect options to extend or terminate the lease when it is reasonably certain that the option will be exercised. For leases that include residual value guarantees or payments for terminating the lease, the Company includes these costs in the lease liability when it is probable that we will incur them. ROU assets and obligations for short-term leases (leases with an initial term of 12 months or less) are not recognized in the Company's Condensed Consolidated Balance Sheets. Lease expense for short-term leases is recognized on a straight-line basis over the lease term.

Results for reporting periods beginning after January 1, 2019 are presented under Accounting Standards Codification ("ASC") 842, Leases ("ASC 842"), while prior period amounts are not adjusted and continue to be reported in accordance with our historical accounting treatment under ASC Topic 840, Leases .

Reclassifications

Certain amounts in the prior period Condensed Consolidated Financial Statements have been reclassified to conform to the current period's presentation specifically as it relates to assets and liabilities held for sale and disaggregated revenue.

2. Discontinued Operations

During the first quarter of 2019, the Company started a process to divest its blow molding business as it is no longer considered a strategic fit with the Company's long-term growth plan and operational objectives. This expected divestiture represents a strategic shift in the Company's business and, in accordance with U.S. GAAP, qualifies as a discontinued operation and the divestiture is expected to occur within one year. As a result, the operating results and cash flows related to the blow molding business have been reflected as discontinued operations in the Company's Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Cash Flows for all periods presented, while the assets and liabilities that are expected to be sold have been reflected as assets and liabilities held for sale for the current and prior periods in the Company's Condensed Consolidated Balance Sheets. The financial information reported for the Company's Advanced Plastic Processing Technologies reporting segment exclude the activity from the blow molding business due to the expected divestiture.

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2. Discontinued Operations (continued)

The assets and liabilities of the blow molding business that have been classified as held for sale in the Company's Condensed Consolidated Balance Sheets are comprised of the following:



	March 31, 2019		December 31, 2018
	(in millions)
Accounts receivable, net	$	8.8	$	6.5
Inventories, net:	18.7		19.3
Prepaid and other current assets	1.0		1.5
Property and equipment, net	16.4		—
Operating lease right-of-use assets	1.2		—
Goodwill	0.6		—
Intangible assets, net	0.8		—
Current assets held for sale	$	47.5	$	27.3

Property and equipment, net	$	—	$	25.3
Goodwill	—		0.6
Intangible assets, net	—		1.1
Noncurrent assets held for sale	$	—	$	27.0

Accounts payable	$	5.3	$	6.1
Advanced billings and deposits	6.1		5.6
Accrued salaries, wages and other compensation	1.5		1.9
Other current liabilities	1.7		1.3
Operating lease liabilities	1.2		—
Current liabilities held for sale	$	15.8	$	14.9

As a result of the Company's decision to sell its blow molding business, the Company recognized an $8.5 million non-cash adjustment to write-down the net book value of one its facilities located in Europe which is classified as held for sale as of March 31, 2019 and December 31, 2018. The facility was written down to fair value less estimated costs to sell based on a quoted market price, a level two measurement under the fair value hierarchy. The facility's assets are recorded within the Company's Advanced Plastic Processing Technologies segment and the adjustment to net book value is recorded within loss on discontinued operations within the Company's Condensed Consolidated Statements of Operations. The value of the facility is classified within current assets held for sale in the accompanying Condensed Consolidated Balance Sheets.

The following table presents a consolidation of the captions within the Company's Condensed Consolidated Statements of Operations for the loss from discontinued operations attributable to the blow molding business for the three months ended March 31, 2019 and 2018.



	Three Months Ended March 31,
	2019			2018
	(in millions)
Loss from discontinued operations attributable to blow molding business
Net sales	$	21.5		$	21.6
Cost of sales	18.7			17.6
Selling, general and administrative expenses	3.1			4.0
Amortization expense	0.4			0.5
Gain on currency translation	—			(0.5		)
Other expense	8.9			0.1
Pretax loss from discontinued operations	(9.6		)	(0.1		)
Income tax expense	0.4			0.5
Loss from discontinued operations	$	(10.0	)	$	(0.6	)

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

3. Revenue

The following table provides information about disaggregated revenue by primary geographical and end markets, and includes a reconciliation of the disaggregated revenue with reportable segments. During the first quarter of 2019, the Company refined the end market classification of certain customers in each segment and as a result, the end market classification in the comparative period has been reclassified to conform with the current period presentation.



	Three Months Ended March 31, 2019
	Advanced Plastic Processing Technologies		Melt Delivery and Control Systems		Fluid Technologies		Total
	(in millions)
Primary geographical markets:
North America	$	74.1	$	36.2	$	12.6	$	122.9
Europe	6.2		28.3		11.4		45.9
China	0.9		21.0		2.5		24.4
India	32.3		3.9		0.2		36.4
Other	5.9		10.6		2.6		19.1
Total	$	119.4	$	100.0	$	29.3	$	248.7

End markets:
Automotive	$	23.4	$	23.3	$	6.2	$	52.9
Packaging	13.7		11.8		—		25.5
Consumer goods	16.2		17.6		1.4		35.2
Electronics	8.0		4.8		1.0		13.8
Medical	6.6		8.1		0.2		14.9
Construction	20.0		0.4		—		20.4
Custom molders and other	31.4		—		—		31.4
Mold makers and other	—		30.8		—		30.8
Job shops and other	—		—		9.1		9.1
Distributors	0.1		3.2		11.4		14.7
Total	$	119.4	$	100.0	$	29.3	$	248.7

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

3. Revenue (continued)



	Three Months Ended March 31, 2018
	Advanced Plastic Processing Technologies		Melt Delivery and Control Systems		Fluid Technologies		Total
	(in millions)
Primary geographical markets:
North America	$	80.3	$	35.8	$	12.8	$	128.9
Europe	16.6		33.2		12.6		62.4
China	5.0		32.1		2.8		39.9
India	31.4		3.8		0.3		35.5
Other	7.0		11.6		3.5		22.1
Total	$	140.3	$	116.5	$	32.0	$	288.8

End markets:
Automotive	$	21.6	$	29.1	$	6.8	$	57.5
Packaging	22.6		12.0		0.1		34.7
Consumer goods	14.9		21.8		1.4		38.1
Electronics	11.3		9.1		1.8		22.2
Medical	4.3		7.6		0.2		12.1
Construction	25.3		0.4		—		25.7
Custom molders and other	40.1		—		—		40.1
Mold makers and other	—		34.0		—		34.0
Job shops and other	—		—		8.9		8.9
Distributors	0.2		2.5		12.8		15.5
Total	$	140.3	$	116.5	$	32.0	$	288.8

We receive payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to receive consideration becomes unconditional. Contract liabilities include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract.

Significant changes in the contract liabilities balances are as follows:



	Three Months Ended March 31, 2019			Three Months Ended March 31, 2018
	(in millions)
Balance at beginning of period	$	38.9		$	52.4
Additional advanced billings and deposits received	71.8			93.3
Revenue recognized	(66.5		)	(80.5		)
Foreign currency translation adjustments and other	(0.6		)	(0.5		)
Balance at end of period	$	43.6		$	64.7

Sales, value-add, and other taxes collected concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. The expected costs associated with our base warranties and field service actions are recognized as expense when the products are sold.

The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling, general and administrative expenses in the Condensed Consolidated Statements of Operations. As permitted by ASU No. 2014-09, Revenue from Contracts w ith Customers , the Company does not disclose the value of unsatisfied performance obligations for (1) contracts with an original expected length of one year or less, and (2) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

4. Goodwill and Other Intangible Assets

The following table summarizes the changes in the Company’s goodwill, by reportable segment, for the three months ended March 31, 2019 :



	Advanced Plastic Processing Technologies		Melt Delivery and Control Systems		Fluid Technologies		Corporate		Total
	(in millions)
Balance at December 31, 2018	$	35.0	$	431.3	$	46.9	$	—	$	513.2
Foreign currency translation adjustments	—		7.1		—		—		7.1
Balance at March 31, 2019	$	35.0	$	438.4	$	46.9	$	—	$	520.3

There were no goodwill impairment charges during the three months ended March 31, 2019 and 2018 .

The following table summarizes the Company’s other intangible assets at March 31, 2019 :



	Gross Amount		Accumulated Amortization		Net Amount
	(in millions)
Intangible assets subject to amortization:
Trademarks	$	36.2	$	20.5	$	15.7
Technology	112.4		55.8		56.6
Customer relationships	215.1		133.9		81.2
Total intangible assets subject to amortization	363.7		210.2		153.5
Trademarks, not subject to amortization	137.5		—		137.5
Total	$	501.2	$	210.2	$	291.0

The following table summarizes the Company’s other intangible assets at December 31, 2018 :



	Gross Amount		Accumulated Amortization		Net Amount
	(in millions)
Intangible assets subject to amortization:
Trademarks	$	35.7	$	19.6	$	16.1
Technology	110.9		53.0		57.9
Customer relationships	213.7		130.7		83.0
Total intangible assets subject to amortization	360.3		203.3		157.0
Trademarks, not subject to amortization	135.7		—		135.7
Total	$	496.0	$	203.3	$	292.7

Consolidated amortization expense related to intangible assets subject to amortization was $5.6 million and $6.3 million for the three months ended March 31, 2019 and 2018 , respectively.

5. Income Taxes

An estimated annual effective tax rate is used to determine the quarterly provision for income taxes. The effective rate is based on various factors including expected annual income, statutory tax rates, tax planning strategies in the various jurisdictions in which the Company operates, permanent items, valuation allowances against deferred tax assets and the ability to utilize tax credits and net operating loss carryforwards. Subsequent recognition, derecognition and measurement of uncertain tax positions are separately recognized in the quarter in which the underlying transaction or event occurs which causes variability in the effective tax rates from quarter to quarter.

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

5. Income Taxes (continued)

The effective rate for each period differs from the U.S. federal statutory income tax rate due to the mix of earnings by jurisdiction and the effect of transaction costs and business combination accounting adjustments that do not provide tax benefits. The valuation allowances also cause volatility in the effective rate as they reduce deferred tax assets in jurisdictions which lack sufficient positive evidence regarding the ability to utilize the assets and no tax benefit or expense is recognized for losses or income incurred in those jurisdictions.

At December 31, 2018, the Company had estimated U.S. net operating loss carryforwards totaling $107.3 million , which are scheduled to expire beginning in 2029. As of December 31, 2018, the Company had determined that it has experienced multiple ownership changes under Internal Revenue Code Section 382 in prior years. During the year ended December 31, 2018, the Company completed a formal study and determined the usage of the Company's U.S. net operating losses are limited due to ownership changes that occurred in 2015 and 2017. The annual limitation did not increase U.S. cash taxes or income tax expense.

In accordance with ASC 740, Income Taxes , the Company records interest and penalties associated with uncertain tax positions within income tax expense in the Company's Condensed Consolidated Statements of Operations. The Company does not have a material liability recorded for interest and penalties related to uncertain tax positions for any period presented.

6. Debt

Debt for the Company consists of the following:



	March 31, 2019								December 31, 2018
	Principal			Unamortized Discount and Debt Issuance Costs		Net			Principal			Unamortized Discount and Debt Issuance Costs		Net
	(in millions)
Senior secured term loan facility due September 2023	$	832.5		$	8.2	$	824.3		$	837.5		$	8.7	$	828.8
Borrowings under other lines of credit	3.1			—		3.1			5.8			—		5.8
Capital lease obligations and other	—			—		—			0.3			—		0.3
Total debt	835.6			8.2		827.4			843.6			8.7		834.9
Less current portion	(3.1		)	—		(3.1		)	(5.9		)	—		(5.9		)
Total debt less current portion	$	832.5		$	8.2	$	824.3		$	837.7		$	8.7	$	829.0

On February 28, 2018, the Company made a voluntary $25.0 million principal payment on the senior secured term loan facility due September 2023 ("2017 Term Loan Facility"). As a result of the transaction, the Company recognized a loss on debt extinguishment of $0.3 million for the three months ended March 31, 2018 related to the write-off of deferred financing costs associated with the Company's 2017 Term Loan Facility.

7. Employee Benefit Plans

The Company sponsors three noncontributory defined benefit pension plans for certain non-U.S. employees and retirees. One plan covers certain employees in the United Kingdom and the other two plans cover certain employees in Germany. The service cost was $0.1 million for the three months ended March 31, 2018 and is included in cost of sales and selling, general and administrative expenses in the Company's Condensed Consolidated Statements of Operations. The other components of net periodic pension costs totaled $0.2 million and $0.3 million for the three months ended March 31, 2019 and 2018 , respectively, and are included in other non-operating expenses in the Company's Condensed Consolidated Statements of Operations.

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

8. Net Earnings Per Share

The following is a reconciliation of the numerator and denominator of the basic and diluted net earnings per share ("EPS") computations:



	Three Months Ended March 31,
	2019		2018
	(in millions, except common share and per common share amounts)
Numerator:
Net earnings from continuing operations	$	9.2	$	6.5
Denominator:
Denominator for basic EPS–weighted-average common shares	69,996,588		69,215,457
Dilutive effect of stock-based compensation arrangements	1,176,893		2,307,869
Denominator for diluted EPS–adjusted weighted-average common shares	71,173,481		71,523,326

Basic EPS from continuing operations	$	0.13	$	0.09
Diluted EPS from continuing operations	$	0.13	$	0.09

The diluted EPS calculation for the three months ended March 31, 2019 and 2018 excludes the effect of 1.1 million and 0.9 million outstanding stock options, respectively, as their effect is anti-dilutive. The diluted EPS calculation for the three months ended March 31, 2019 and 2018 excludes the effect of 0.5 million and 0.2 million outstanding performance stock units, respectively, as the performance criteria has not yet been achieved.

9. Stock-based Compensation

On March 1, 2019, the Company granted 0.3 million performance stock units and 0.8 million restricted stock units under the 2015 Equity Incentive Plan. The performance stock units contain a three -year performance period with a performance target based on adjusted EBITDA margin and free cash flow conversion and possible payouts ranging from 50% to 200% of the target awards. The restricted stock units vest in equal annual increments over two or three years .

10. Derivative Financial Instruments

In the normal course of business, including the purchasing of materials and selling of products, the Company is exposed to certain risks related to fluctuations in foreign currency exchange rates. The Company uses foreign currency forward contracts to manage risks from these market fluctuations. The Company is also exposed to certain risks related to fluctuations in interest rates and uses interest rate swaps to manage risk from these market fluctuations. The counterparties to these financial instruments are financial institutions with strong credit ratings. The Company maintains control over the size of positions entered into with any one counterparty and monitors the credit ratings of these institutions.

Foreign Currency Forward Contracts

The Company currently hedges its risk relative to fluctuations in the Canadian dollar, Euro and Japanese yen for forecasted cash outflows denominated in these currencies. The Company had foreign currency forward contracts denominated in these currencies outstanding with notional amounts totaling $34.3 million at March 31, 2019 . There were no foreign currency forward contracts outstanding at December 31, 2018 . As of March 31, 2019 , all of the Company’s outstanding instruments mature within the next nine months .

The Company’s derivative instruments discussed above are designated as cash flow hedges and the fair value of these derivative instruments was $0.2 million at March 31, 2019 and is included in prepaid and other current assets in the Company's Condensed Consolidated Balance Sheets.

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

10. Derivative Financial Instruments (continued)

The Company also enters into derivative instruments (forwards) to economically hedge the impact of fluctuations in the Indian rupee. During the three months ended March 31, 2019 , the Company recognized losses of $0.2 million related to the changes in fair value of these derivative instruments not designated as hedges. These gains and losses are recognized immediately within the Company's Condensed Consolidated Statements of Operations and are classified within (gain) loss on currency translation. The fair value of these derivative instruments not designated as hedges was insignificant at March 31, 2019 .

Interest Rate Swap Agreements

The Company is exposed to changes in interest rates on its variable rate debt. In order to manage this risk, on February 16, 2017, Milacron LLC, a wholly-owned subsidiary of the Company, entered into two interest rate swap transactions effective for a four-year period beginning January 31, 2018 with a total notional amount of $400.0 million . The interest rate swaps are intended to manage the Company's interest rate risk by fixing the interest rate on a portion of the Company's debt outstanding under the 2017 Term Loan Facility that was previously subject to a floating interest rate equal to 1-month LIBOR plus a credit spread. The swaps provide for the Company to pay a fixed rate of 2.062% per annum on such portion of the outstanding debt in exchange for receiving a variable interest rate based on 1-month LIBOR. The effect is a synthetically fixed rate of 2.062% plus the loan spread for the term and debt hedged.

The Company designated these interest rate swaps as cash flow hedges of floating rate borrowings and expects the hedge to be highly effective in offsetting fluctuations in the designated interest payments resulting from changes in the benchmark interest rate. The gains and losses on the designated interest rate swaps will offset losses and gains on the transactions being hedged. The fair value of the interest rate swaps is calculated by taking into consideration current interest rates and the current creditworthiness of the counterparties or the Company, as applicable. The effective portion of changes in the fair value of the interest rate swaps is reflected as a component of accumulated other comprehensive loss and recognized as interest expense, net as payments are paid or accrued. The remaining gain or loss in excess of the cumulative change in the present value of the future cash flows of the hedge item, if any (i.e. the ineffective portion), is recognized as interest expense, net during the current period. During the three months ended March 31, 2018, the Company recorded $0.1 million of hedge ineffectiveness in earnings.

Cross-Currency Interest Rate Swap

In November 2018, the Company entered into a cross-currency interest rate swap agreement that will mature on September 28, 2023, with an aggregate notional amount of $85.8 million to manage foreign currency risk by effectively converting a portion of the Company's variable rate U.S. dollar-denominated debt, including the monthly interest rates thereunder, to fixed rate Euro-denominated debt of €75.0 million. This cross-currency interest rate swap agreement is designated as a hedge of a portion of our net investment in Euro-denominated foreign operations to reduce foreign currency risk associated with the investment in these operations. Changes in the value of these items resulting from fluctuations in the underlying exchange rates to U.S. dollar exchange rates are recorded as foreign currency translation adjustments within accumulated other comprehensive loss.

The following table provides the effect of the Company’s foreign currency forward contracts, interest rate swaps and cross-currency interest rate swaps designated as cash flow hedges on the Company’s Condensed Consolidated Financial Statements for the three months ended March 31, 2019 and 2018 :



Type of instrument:	Gain (Loss) Recognized in OCI on Derivative (Effective Portion)			Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
	(in millions)
Three Months Ended March 31, 2019
Foreign exchange contracts	$	0.3		$	—
Interest rate swaps	$	(3.5	)	$	0.5
Cross-currency interest rate swaps	$	2.3		$	0.5
Three Months Ended March 31, 2018
Foreign exchange contracts	$	(0.2	)	$	—
Interest rate swaps	$	5.8		$	—

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

10. Derivative Financial Instruments (continued)

All gains (losses) that are reclassified from accumulated other comprehensive loss into income (effective portion) are classified in (gain) loss on currency translation or cost of sales within the Company's Condensed Consolidated Statements of Operations. The gain (loss) recognized related to the ineffective portion of the foreign exchange contracts was immaterial for all periods presented.

Fair Value Measurements

The Company estimates the fair value of its financial instruments utilizing an established three-level hierarchy. The hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date as follows:


•	Level 1–Valuation is based upon unadjusted quoted prices for identical assets or liabilities in active markets.


•	Level 2–Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial statements.


•	Level 3–Valuation is based upon other unobservable inputs that are significant to the fair value measurements.

The classification of fair value measurements within the established three-level hierarchy is based upon the lowest level of input that is significant to that measurement. The fair values of the Company’s derivative instruments were measured using valuations based upon quoted prices for similar assets and liabilities in active markets (Level 2) and are valued by reference to similar financial instruments, adjusted for terms specific to the contracts. There were no transfers between the three levels of the fair value hierarchy during any period presented. The derivative assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018 were as follows:



	Balance Sheet Location	Total		Level 1		Level 2		Level 3
		(in millions)
March 31, 2019
Foreign currency forward contracts (asset position)	Prepaid and other current assets	$	0.2	$	—	$	0.2	$	—
Interest rate swap agreements (asset position)	Prepaid and other current assets	$	1.3	$	—	$	1.3	$	—
Interest rate swap agreements (liability position)	Other current liabilities	$	0.1	$	—	$	0.1	$	—
Cross-currency interest rate swap agreements (asset position)	Prepaid and other current assets	$	2.1	$	—	$	2.1	$	—
Cross-currency interest rate swap agreements (asset position)	Other noncurrent assets	$	0.1	$	—	$	0.1	$	—
Cross-currency interest rate swap agreements (liability position)	Other current liabilities	$	0.4	$	—	$	0.4	$	—
Cross-currency interest rate swap agreements (liability position)	Other noncurrent accrued liabilities	$	0.9	$	—	$	0.9	$	—
December 31, 2018
Interest rate swap agreements (asset position)	Prepaid and other current assets	$	1.9	$	—	$	1.9	$	—
Cross-currency interest rate swap agreements (asset position)	Prepaid and other current assets	$	1.9	$	—	$	1.9	$	—
Interest rate swap agreements (asset position)	Other noncurrent assets	$	2.5	$	—	$	2.5	$	—
Cross-currency interest rate swap agreements (liability position)	Other current liabilities	$	0.3	$	—	$	0.3	$	—
Cross-currency interest rate swap agreements (liability position)	Other noncurrent accrued liabilities	$	2.1	$	—	$	2.1	$	—

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

11. Accumulated Other Comprehensive Loss

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive loss:



	Foreign Currency Translation			Unrecognized Post- Retirement Plan Losses			Derivative Financial Instruments			Total
	(in millions)
Balance at December 31, 2017	$	(78.3	)	$	(7.2	)	$	0.1		$	(85.4	)
Other comprehensive income (loss) before reclassifications	26.6			(0.1		)	4.4			30.9
Amounts reclassified from accumulated other comprehensive loss	—			0.1			—			0.1
Other comprehensive income	26.6			—			4.4			31.0
Balance at March 31, 2018	$	(51.7	)	$	(7.2	)	$	4.5		$	(54.4	)

Balance at December 31, 2018	$	(132.5	)	$	(5.2	)	$	2.8		$	(134.9	)
Other comprehensive income (loss) before reclassifications	11.1			—			(0.8		)	10.3
Amounts reclassified from accumulated other comprehensive loss	—			0.1			(0.8		)	(0.7		)
Other comprehensive income (loss)	11.1			0.1			(1.6		)	9.6
Balance at March 31, 2019	$	(121.4	)	$	(5.1	)	$	1.2		$	(125.3	)

The following table summarizes the reclassifications out of accumulated other comprehensive loss during the three months ended March 31, 2019 and 2018 :



	Classification	Three Months Ended March 31,
	of Expense	2019			2018
		(in millions)
Unrealized pension and post-retirement obligations:
Adjustment of pension and post-retirement obligations	(a)	$	(0.1	)	$	(0.1	)
Tax benefit	(c)	—			—
Adjustment of pension and post-retirement obligations, net of tax		(0.1		)	(0.1		)
Derivative financial instruments:
Loss on derivative financial instruments	(b)	1.0			—
Tax benefit	(c)	(0.2		)	—
Loss on derivative financial instruments, net of tax		0.8			—
Total reclassifications from accumulated other comprehensive loss		$	0.7		$	(0.1	)


(a)	Amount is included in the calculation of pension cost within other non-operating expenses in the Company's Condensed Consolidated Statements of Operations.


(b)	Amount is included in cost of sales and (gain) loss on currency translation in the Company's Condensed Consolidated Statements of Operations.


(c)	These amounts are included in income tax expense in the Company's Condensed Consolidated Statements of Operations.

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

12. Warranty Reserves

A reserve for estimated warranty costs is recorded at the time of sale of machinery and parts and is periodically adjusted to reflect actual experience.

The following table summarizes changes in the Company’s warranty reserves for the periods indicated. Accrued warranty reserves are included in other current liabilities in the Company's Condensed Consolidated Balance Sheets:



		Three Months Ended March 31,
		2019			2018
	(in millions)
Balance at beginning of period		$	8.7		$	9.7
Warranty expense		2.5			3.9
Warranty claims paid		(3.3		)	(3.7		)
Foreign currency translation adjustments		0.1			0.1
Balance at end of period		$	8.0		$	10.0

13. Restructuring and Facilities

2019 Actions

During the three months ended March 31, 2019 , the Company entered into an agreement to purchase a manufacturing facility located in Baden-Baden, Germany which was previously leased by the Company. The purchase price was €6.8 million , or approximately $7.8 million . In connection with this transaction, the Company has committed to a plan to sell the facility with the intention of entering into a corresponding new lease agreement. As of March 31, 2019, this facility met the held-for-sale criteria set forth in U.S. GAAP, resulting in the classification of $8.0 million of property and equipment as held-for-sale. No adjustment to book value was recognized during the three months ended March 31, 2019 and the book value of the facility is classified within current assets held for sale in the Company's Condensed Consolidated Balance Sheets. The Baden-Baden, Germany facility is reported within the Melt Delivery and Control Systems segment.

2018 Actions

In connection with the Company's organizational redesign initiatives in Europe, the Company has committed to a plan to sell its facility located in Malterdingen, Germany. As of March 31, 2019 and December 31, 2018, this facility met the held-for-sale criteria set forth in U.S. GAAP, resulting in the classification of $9.5 million of property and equipment as held-for-sale. No adjustment to book value was recognized during the three months ended March 31, 2019 and the book value of the facility is classified within current assets held for sale in the Company's Condensed Consolidated Balance Sheets. The Malterdingen, Germany facility is reported within the Advanced Plastic Processing Technologies segment.

2016 Actions

On September 30, 2016, the Company's wholly-owned subsidiary Ferromatik Milacron GmbH entered into an agreement with its local works council setting forth a restructuring plan related to its manufacturing facility in Malterdingen, Germany whereby certain operational functions will be shifted to the Company's operations in the Czech Republic, United States and India. During the three months ended March 31, 2018, the Company identified additional employees to be included within the Company's existing restructuring plan. During the three months ended March 31, 2018, the Company recorded severance expense of $6.4 million related to this restructuring plan which is included within other expense, net in the Company's Condensed Consolidated Statements of Operations. Substantially all of these costs resulted in cash expenditures and were substantially complete by March 31, 2019. As the employees were required to render service in order to receive the termination benefits, the associated liability and expense were recognized ratably over the future service period. At December 31, 2018, the total remaining liability related to this plan was $8.3 million and is included in other current liabilities in the Company's Condensed Consolidated Balance Sheets.

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

14. Leases

We have operating leases primarily for manufacturing facilities, offices, vehicles, and certain equipment. Leases with an initial term of 12 months or less are not recorded on the Company's Condensed Consolidated Balance Sheets with lease expense for these leases recognized on a straight-line basis over the lease term. Our leases have remaining lease terms of 1 year to 13 years , some of which may include options to extend the leases for up to 20 years , and some of which may include options to terminate the leases within 1 year . Operating lease expense for the three months ended March 31, 2019 was $3.0 million while financing and short-term lease expenses were insignificant.

Supplemental cash flow information for the three months ended March 31, 2019 are as follows (in millions):



Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	3.0

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	3.5

Supplemental balance sheet information related to leases at March 31, 2019 are as follows (in millions, except remaining lease term and discount rate):



Operating Leases:
Operating lease right-of-use assets	$	34.2

Other current liabilities	$	7.9
Operating lease liabilities	26.4
Total operating lease liabilities	$	34.3

Weighted-Average Remaining Lease Term (in years):
Operating leases	6.56

Weighted-Average Discount Rate:
Operating leases	5.16%

At March 31, 2019, the maturities of operating lease liabilities are as follows (in millions):



2019 (excluding the three months ended March 31, 2019)	$	7.8
2020	8.5
2021	6.5
2022	4.9
2023	3.8
Thereafter	11.8
Total lease payments	43.3
Less: Imputed interest	(9.0		)
Total	$	34.3

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

14 Leases (continued)

At December 31, 2018, future minimum lease commitments under non-cancelable operating leases as determined prior to the adoption of ASC 842 were as follows (in millions):



2019	$	8.9
2020	6.2
2021	4.4
2022	3.5
2023	2.5
Thereafter	2.9
Future minimum leas commitments	$	28.4

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

15. Business Segment Information

The Company’s operations are principally managed based upon the products that are produced and are comprised of three operating segments, which are the same as the Company’s reportable segments: Advanced Plastic Processing Technologies, Melt Delivery and Control Systems, and Fluid Technologies. The factors for determining the Company’s reportable segments include the manner in which management evaluates performance combined with the nature of the individual business activities. The Company evaluates the performance of its segments based on net sales and operating earnings. Operating earnings includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segments. Operating earnings for each segment excludes items that are of a non-operating nature or are of a corporate or functional governance nature. Costs excluded from segment operating earnings include interest expense, income taxes and various corporate expenses such as transaction costs associated with the acquisition of certain businesses, stock-based compensation expense and other separately managed general and administrative costs. The effects of intersegment transactions have been eliminated.

The following table summarizes total assets by segment:



	March 31, 2019		December 31, 2018
	(in millions)
Advanced Plastic Processing Technologies	$	492.6	$	482.3
Melt Delivery and Control Systems	1,054.1		1,030.6
Fluid Technologies	149.3		145.3
Corporate	48.3		74.3
Total assets	$	1,744.3	$	1,732.5

The following table summarizes long-lived assets, net by segment:



	March 31, 2019		December 31, 2018
	(in millions)
Advanced Plastic Processing Technologies	$	98.2	$	82.1
Melt Delivery and Control Systems	113.4		109.6
Fluid Technologies	23.3		17.7
Corporate	7.5		6.3
Total long-lived assets, net	$	242.4	$	215.7

The following tables summarize segment information:



		Three Months Ended March 31,
		2019		2018
	(in millions)
Net sales to external customers:
Advanced Plastic Processing Technologies		$	119.4	$	140.3
Melt Delivery and Control Systems		100.0		116.5
Fluid Technologies		29.3		32.0
Total net sales to external customers		$	248.7	$	288.8

Table of Contents

MILACRON HOLDINGS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

15. Business Segment Information (continued)



		Three Months Ended March 31,
		2019			2018
	(in millions)
Operating earnings (loss):
Advanced Plastic Processing Technologies		$	12.1		$	2.7
Melt Delivery and Control Systems		18.4			26.7
Fluid Technologies		5.4			6.0
Corporate		(10.0		)	(12.2		)
Total operating earnings		$	25.9		$	23.2
Capital expenditures:
Advanced Plastic Processing Technologies		$	6.3		$	2.2
Melt Delivery and Control Systems		11.0			4.1
Fluid Technologies		0.7			0.6
Corporate		—			0.3
Total capital expenditures		$	18.0		$	7.2
Depreciation and amortization:
Advanced Plastic Processing Technologies		$	2.7		$	3.3
Melt Delivery and Control Systems		7.8			8.5
Fluid Technologies		1.0			1.1
Corporate		0.4			0.3
Total depreciation and amortization		$	11.9		$	13.2

The following tables summarize net sales to external customers and long-lived assets, net by country:



		Three Months Ended March 31,
		2019		2018
	(in millions)
Net sales to external customers:
United States		$	103.0	$	108.4
China		24.4		39.9
India		36.4		35.5
Rest of World		84.9		105.0
Total net sales to external customers		$	248.7	$	288.8



	March 31, 2019		December 31, 2018
	(in millions)
Long-lived assets, net:
United States	$	76.5	$	63.3
China	53.0		48.4
India	42.0		37.9
Czech Republic	18.9		18.7
Canada	26.9		29.0
Rest of World	25.1		18.4
Total long-lived assets, net	$	242.4	$	215.7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

For an understanding of the significant factors that influenced our results, the following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this report. This management’s discussion and analysis should also be read in conjunction with the management’s discussion and analysis and consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the SEC on February 28, 2019.

Overview

Milacron Holdings Corp. ("Milacron", the "Company", "we", "us" or "our") is a global leader in the manufacture, distribution, and service of highly engineered and customized systems within the plastic technology and processing industry. We serve this market through the following three segments:


•	Advanced Plastic Processing Technologies (“APPT”);


•	Melt Delivery and Control Systems (“MDCS”); and


•	Fluid Technologies (“Fluids”).

Our APPT segment designs, manufactures and sells plastic processing equipment and systems, which include injection molding, blow molding, extrusion and auxiliary systems along with the related parts and service, whereas our MDCS segment designs, manufactures and sells hot runner and process control systems, mold bases and components, and sells maintenance, repair and operating (“MRO”) supplies. Hot runner systems are designed for each product a customer manufactures on an injection molding machine. Our Fluids segment is a global manufacturer of synthetic and semi-synthetic lubricants and coolants.

We are the only global company with a full-line product portfolio that includes hot runner systems, injection molding, blow molding and extrusion equipment. We maintain strong market positions across these products, as well as leading positions in process control systems, mold bases and components, MRO supplies and fluid technology.

Milacron has strong brand recognition with over 150 years of continuous operations. With products sold in over 100 countries across six continents, our established and market-driven global footprint is well-positioned to benefit from continued robust industry growth in both developed and emerging markets. Our breadth of products, long history, and global reach have resulted in a large installed base of plastic processing machines and hot runner systems.

Our strategy is designed to maximize revenue from consumable products across the life of a machine, while offering plastic technology solutions to a broad customer base. Management estimates that the value of available consumables revenue across the life of a machine is one to four times the cost of a machine. This strategy has shifted our revenue and earnings model to be more heavily weighted towards consumables, which comprise the majority of revenue from our plastic processing related APPT and MDCS segments on a combined basis. The consumables portion of our APPT and MDCS segments consists of: (1) machine aftermarket parts and service which are required annually, (2) hot runner systems and mold bases which are required each time new plastic parts are designed and existing plastic parts are redesigned, and (3) upgrades and overhauls which occur as customers decide to improve the performance or extend the life of their machines. Upon a customer’s decision to replace a machine, we can repurchase the existing machine and sell it as a certified pre-owned machine. All of our sales in our MDCS and Fluids segments are considered to be consumable and, when combined with our APPT consumable product lines, consumables accounted for 67% of total fiscal 2018 sales and 73% of our sales for the three months ended March 31, 2019 . We believe this percentage will increase as we capture more of our customers’ spend on consumable products through our lifecycle sales approach.

Our customers consist of many blue-chip and Fortune 500 companies including OEMs, molders and mold-makers. Our customer base covers a wide range of end market applications including packaging, automotive, medical, construction, consumer goods and electronics. Our sales are geographically diversified, with 49% in North America, 18% in Europe, 10% in China, 15% in India and 8% in the rest of the world for the three months ended March 31, 2019 .

Global population growth, coupled with continued urbanization, increased purchasing power and improved lifestyle in emerging markets has resulted in greater demand for a broad range of finished plastic products in many segments of the economy, including automotive, construction and consumer products. We believe that our strong global presence positions us well to capture a portion of this growth. Milacron has made significant investments in China and India in order to capitalize on the projected growth rates of the plastic business in these markets. We plan to continue to expand our manufacturing capabilities while also increasing our technical, marketing and sales efforts. We also continue to strategically reorganize our manufacturing base in order to shift resources to high growth geographic markets.

Discontinued Operations

During the first quarter of 2019, the Company started a process to divest its blow molding business as it is no longer considered a strategic fit with the Company's long-term growth and operational objectives. This expected divestiture represents a strategic shift in Milacron's business and, in accordance with United States generally accepted accounting principles ("U.S. GAAP"), qualifies as a discontinued operation and the divestiture is expected to occur within one year. As a result, the operating results and cash flows related to the blow molding business have been reflected as discontinued operations in the Company's Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Cash Flows for all periods presented, while the assets and liabilities that are expected to be sold have been reflected as assets and liabilities held for sale for the current and prior periods in the Company's Condensed Consolidated Balance Sheets. The financial information reported for the Company's Advanced Plastic Processing Technologies reporting segment exclude the activity from the blow molding business due to the expected divestiture.

Key Drivers of our Businesses

Milacron’s strategy is focused on growing revenue and operating profits through selective initiatives that leverage our market position, geographic footprint and core competencies. Management expects, in the near term, profitability will be driven by both revenue growth and margin expansion. Management expects that revenue growth will come from underlying market growth in our key segments, geographic expansion of certain product lines, continued penetration of hot runners and incremental share gain from new products. New products are focused on solidifying our current market position, expanding our addressable market and expanding the market through the introduction of technology that displaces other materials, primarily metal and glass. Operating margin expansion is expected to result from active cost reduction initiatives focused on leveraging our geographic footprint that will allow us to consolidate manufacturing capacity, sales offices and call centers on a regional basis, and shift certain back-office functions from a decentralized local structure to a low-cost country global shared service center model.

Advanced Plastic Processing Technologies

The key factors affecting our APPT segment results include demand for plastic processing machinery, raw material inputs and cost structure.

Demand. Increased demand in the plastic processing machinery industry is expected to be driven by the overall expected rise in plastic processing, increasing equipment age and continuing advances in technology, such as the shift to higher-end equipment as plastic processors seek to reduce their operating costs and produce higher quality products. With 62% of APPT sales for the three months ended March 31, 2019 occurring in North America, demand is also impacted by customers bringing manufacturing operations back to North America.

Raw Material Inputs. Steel, which we source both directly and indirectly through our component suppliers, is the primary material used in our products. We do not enter into derivative financial instruments to hedge our commodity price risk and currently do not have a significant number of long-term supply contracts with key suppliers. In order to secure our supply needs, we have developed a global network of reliable, low-cost suppliers.

Cost Structure. Our APPT segment is focused on optimizing our global manufacturing and back-office infrastructure to maximize operating efficiencies and minimize fixed cost structure.

Melt Delivery and Control Systems

The key factors affecting our MDCS segment results include demand for hot runner systems and hot halves, mold bases, components, raw material inputs and cost structure.

Demand. Consistent with historical periods, according to a August 2017 Interconnection Consulting report, the hot runner market is expected to grow faster than the overall global economy based on macro-economic drivers involving product life cycles, demographics, technology conversion and greater use of plastic. Demand within the hot runner market is driven more by the frequency of product design changes and model refreshes than by end product volume, because hot runner systems are typically custom ordered for each new product mold, representing a critical factor in the market’s resiliency during economic cycles.

Raw Material Inputs. Steel is the primary raw material input for our MDCS segment. Although long-term contracts with steel suppliers are not typical, our business has purchase order commitments for a portion of our annual spend of higher-volume grades of steel. These purchase orders extend an average of three to six months, with prices negotiated annually. This allows us to forecast our costs in the MDCS segment and, given the short lead time between the initial request for a quotation and the finalized design, we have historically been able to pass along price changes, accordingly.

Cost Structure. Our MDCS segment is focused on controlling its cost structure by increasing best-cost country sourcing in addition to establishing comprehensive operations in India for applications engineering and the consolidation of several back-office support functions within our shared services center.

Fluid Technologies

The key factors affecting our Fluids segment results include demand for metalworking fluids and raw material inputs.

Demand. Demand for industrial fluids is closely tied to demand for metal products, which are produced on metalworking machinery through cutting, stamping and other processes. As industrial production and demand for metalworking machinery grows, manufacturers will require increased amounts of high-quality coolants, lubricants and cleaners to maximize productivity and extend the life of equipment and tooling. Market trends indicate higher technology fluids demand due to environmental and health concerns and as more exotic metals become more prevalent.

Raw Material Inputs. Many of the raw materials in our industrial fluids are derivatives of petroleum or natural gas. As a result, fluctuations in commodity-based pricing may impact the cost of these materials. We manage the impact of raw material cost increases through sales pricing adjustments, but we may be impacted by a delay in implementing these adjustments throughout our distribution network. In addition, due to the specialty nature of our products, some of our raw materials have few sources, and we may be impacted by disruptions to supply. Where possible, we seek alternative sources and, in some situations, we are able to reformulate product with alternative materials without impacting performance, environmental, or health and safety features.

New Orders and Backlog

New orders represent the value of incoming purchase orders received for a period of time that may or may not have been shipped during the period. New orders in the first three months of 2019 were $275.3 million , a decrease of $33.2 million , or 10.8% , compared to $308.5 million in the first three months of 2018 . Excluding $9.8 million of unfavorable effects of foreign currency movements, new orders decreased 7.6% compared to the prior year period. New orders were primarily impacted by declines in our equipment businesses in North America and Europe and our hot runner businesses in China and Europe. End market declines were primarily driven by the packaging, electronics, consumer goods and construction end markets.

Backlog represents the value of unfilled orders as of the applicable date. These unfilled orders are supported by a valid purchase order and price, terms and credit have been approved by us. Our backlog of unfilled orders at March 31, 2019 was $226.7 million , an increase of $27.5 million from December 31, 2018 and a decrease of $25.8 million from March 31, 2018 . Excluding $0.9 million of favorable effects of foreign currency movements, backlog increased 13.4% compared to December 31, 2018 . The increase in our backlog at March 31, 2019 compared to December 31, 2018 is predominantly driven by our equipment business in North America. Excluding $6.2 million of unfavorable effects of foreign currency movements, backlog decreased 7.8% compared to March 31, 2018 . All of our backlog is expected to be filled within the next twelve months and there are no seasonal or other aspects of the backlog that would impact our ability to fill the orders.

Backlog of confirmed orders for equipment within the APPT business is tracked on a monthly basis. Lead times can vary significantly depending on the type and size of machine. Backlog within our MDCS businesses is relatively stable, as mold bases and hot runner systems have a short lead time from receipt of order to shipment with a global average of six to eight weeks; whereas spare parts sales of standard products are typically in stock and shipped with very little lead time. We do not track backlog in our Fluids segment as most orders are filled with minimal lead time.

Executive Overview

For the first three months of 2019 , we reported sales of $248.7 million , operating earnings of $25.9 million and net earnings from continuing operations of $9.2 million . This compares to sales of $288.8 million , operating earnings of $23.2 million and net earnings from continuing operations of $6.5 million for the first three months of 2018 . Excluding $9.9 million of unfavorable effects of foreign currency movements, sales decreased 10.5% compared to the prior year period. We generated $41.0 million in Adjusted EBITDA, or 16.5% of sales, during the first three months of 2019 compared to $53.6 million in Adjusted EBITDA, or 18.6% of sales, during the first three months of 2018 .

Advanced Plastic Processing Technologies

For the three months ended March 31, 2019 , APPT generated $119.4 million in sales, operating earnings of $12.1 million and $14.7 million in Adjusted EBITDA, or 12.3% of sales, before corporate expenses, compared to $140.3 million in sales, operating earnings of $2.7 million and $16.2 million in Adjusted EBITDA, or 11.5% of sales, before corporate expenses, in the same period of 2018 . Excluding $3.8 million of unfavorable effects of foreign currency movements, sales decreased 12.2% compared to the prior year period.

Melt Delivery and Control Systems

For the three months ended March 31, 2019 , MDCS generated $100.0 million in sales, operating earnings of $18.4 million and $25.8 million in Adjusted EBITDA, or 25.8% of sales, before corporate expenses, compared to $116.5 million in sales, operating earnings of $26.7 million and $38.2 million in Adjusted EBITDA, or 32.8% of sales, before corporate expenses, in the same period of 2018 . Excluding $4.6 million of unfavorable effects of foreign currency movements, sales decreased 10.2% compared to the prior year period.

Fluid Technologies

For the three months ended March 31, 2019 , Fluids generated $29.3 million in sales, operating earnings of $5.4 million and $6.4 million in Adjusted EBITDA, or 21.8% of sales, before corporate expenses, compared to $32.0 million in sales, operating earnings of $6.0 million and $7.1 million in Adjusted EBITDA, or 22.2% of sales, before corporate expenses, in the same period of 2018 . Excluding $1.5 million of unfavorable effects of foreign currency movements, sales decreased 3.8% compared to the prior year period.

Liquidity

In the three months ended March 31, 2019 , cash decreased $34.0 million primarily as a result of capital expenditures, a $5.0 million voluntary payment on the senior secured term loan facility due September 2023 ("2017 Term Loan Facility") as well as the purchase of treasury stock. Operating activities from continuing operations used $4.6 million of cash in the first three months of 2019 compared to generating $11.7 million of cash in the same period of 2018 . The decrease was primarily driven by an increase in working capital. Investing activities from continuing operations used $17.8 million of cash in the first three months of 2019 primarily due to capital expenditures, including the purchase of a manufacturing facility located in Baden-Baden, Germany which was previously leased by the Company. Financing activities from continuing operations used $10.2 million of cash in the first three months of 2019 primarily as a result of our $5.0 million voluntary principal payment on the 2017 Term Loan Facility as well as the purchase of treasury stock.

Cash on hand at March 31, 2019 was $150.0 million , and we had approximately $78.1 million available for borrowing under our asset-based and other credit facilities.

Results of Operations

Comparison of the Three Months Ended March 31, 2019 and 2018

The following table summarizes the results of operations for the three months ended March 31, 2019 and 2018 :



		Three Months Ended March 31,
		2019			2018
	(in millions)
Net sales		$	248.7		$	288.8
Cost of sales		163.9			188.9
Manufacturing margins		84.8			99.9
Operating expenses:
Selling, general and administrative expenses		54.1			62.1
Amortization expense		5.6			6.3
(Gain) loss on currency translation		(0.7		)	0.7
Other (income) expense, net		(0.1		)	7.6
Total operating expenses		58.9			76.7
Operating earnings		25.9			23.2
Interest expense, net		9.5			10.7
Loss on debt extinguishment		—			0.3
Other non-operating expenses		0.2			0.3
Earnings from continuing operations before income taxes		16.2			11.9
Income tax expense		7.0			5.4
Net earnings from continuing operations		9.2			6.5
Loss from discontinued operations (net of income taxes)		(10.0		)	(0.6		)
Net (loss) earnings		$	(0.8	)	$	5.9

We may refer to net sales or other historical financial information on a “constant currency basis,” which is a non-GAAP financial measure. These references to constant currency basis do not include operational impacts that could result from fluctuations in foreign currency rates. To provide information on a constant currency basis, the applicable financial results are adjusted based on a simple mathematical model that translates current period results in local currency using the comparable prior year period’s currency conversion rate. This approach is used for countries where the functional currency is the local country currency. This information is provided so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby facilitating period-to-period comparisons of business performance. Constant currency information is not recognized under United States generally accepted accounting principles ("U.S. GAAP"), and should be considered in addition to, not as a substitute for, results reported in accordance with U.S. GAAP.

Net Sales

For the three months ended March 31, 2019 , sales were $248.7 million compared to $288.8 million for the three months ended March 31, 2018 , a decrease of $40.1 million , or 13.9% . Excluding $9.9 million of unfavorable effects of foreign currency movements, sales decreased 10.5% , on a constant currency basis, compared to the prior year period. Sales were impacted by declines in our equipment businesses in North America and Europe and our hot runner businesses in China and Europe, partially offset by growth in our equipment business in India. End market declines were primarily driven by the packaging, electronics and custom molders end markets.

The following table sets forth our sales by segment for the three months ended March 31, 2019 and 2018 :



		Three Months Ended March 31,
		2019		2018
	(in millions)
Sales by segment:
Advanced Plastic Processing Technologies		$	119.4	$	140.3
Melt Delivery and Control Systems		100.0		116.5
Fluid Technologies		29.3		32.0
Total sales		$	248.7	$	288.8

Advanced Plastic Processing Technologies

Sales for the APPT segment for the three months ended March 31, 2019 were $119.4 million compared to $140.3 million for the three months ended March 31, 2018 , a decrease of $20.9 million , or 14.9% . Excluding $3.8 million of unfavorable effects of foreign currency movements, sales decreased 12.2% , on a constant currency basis, compared to the prior year period. Regionally, sales were impacted by declines in North America and Europe, partially offset by growth in India. End market declines were primarily driven by the packaging, construction and custom molders end markets, partially offset by growth in the automotive, consumer goods and medical end markets.

Melt Delivery and Control Systems

Sales for the MDCS segment for the three months ended March 31, 2019 were $100.0 million compared to $116.5 million for the three months ended March 31, 2018 , a decrease of $16.5 million , or 14.2% . Excluding $4.6 million of unfavorable effects of foreign currency movements, sales decreased 10.2% , on a constant currency basis, compared to the prior year period. Regionally, sales were impacted by declines in China and Europe, partially offset by growth in North America and India. End market declines were primarily driven by the automotive, consumer goods and electronics end markets, partially offset by growth in the medical end market.

Fluid Technologies

Sales for the Fluids segment for the three months ended March 31, 2019 were $29.3 million compared to $32.0 million for the three months ended March 31, 2018 , a decrease of $2.7 million , or 8.4% . Excluding $1.5 million of unfavorable effects of foreign currency movements, sales decreased 3.8% , on a constant currency basis, compared to the prior year period. Regionally, sales were impacted by declines in all major regions. End market declines were primarily driven by the electronics and distributor end markets.

Cost of Sales

Cost of sales for the three months ended March 31, 2019 was $163.9 million compared to $188.9 million for the three months ended March 31, 2018 , a decrease of $25.0 million , or 13.2% . The decrease is primarily due to a decline in sales volumes.

Manufacturing Margins

Our manufacturing margin (or gross margin) for the three months ended March 31, 2019 was $84.8 million compared to $99.9 million for the three months ended March 31, 2018 , a decrease of $15.1 million , or 15.1% . The manufacturing margin as a percent of sales for the three months ended March 31, 2019 was 34.1% compared to 34.6% for the three months ended March 31, 2018 . The decrease in manufacturing margin is primarily related to a decrease in sales volumes within the Company's higher margin segments, MDCS and Fluids, when compared to the prior year.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2019 were $54.1 million compared to $62.1 million for the three months ended March 31, 2018 , a decrease of $8.0 million , or 12.9% . The decrease is primarily related to reductions in structural salary costs, selling costs associated lower sales volumes, certain discretionary costs and favorable foreign currency translation effects.

Amortization Expense

Amortization expense related to intangible assets for the three months ended March 31, 2019 was $5.6 million compared to $6.3 million for the three months ended March 31, 2018 , a decrease of $0.7 million , or 11.1% . The decrease is primarily related to accelerated amortization methods on certain intangible assets subject to amortization as well as favorable foreign currency translation effects.

(Gain) loss on Currency Translation

The gain on currency translation for the three months ended March 31, 2019 was $0.7 million compared to a loss of $0.7 million for the three months ended March 31, 2018 , resulting in a favorable change of $1.4 million . The change primarily relates to the non-cash translation impact on intercompany advances related to the Canadian dollar, the Euro and the Czech koruna within the MDCS and Corporate segments.

Other (Income) Expense, Net

Other (income) expense, net for the three months ended March 31, 2019 was income of $0.1 million compared to expense of $7.6 million for the three months ended March 31, 2018 , an improvement of $7.7 million . The costs recognized within other expense, net in 2018 primarily relate to severance and other related costs incurred in connection with our restructuring plan at our Malterdingen, Germany facility.

Operating Earnings

Operating earnings for the three months ended March 31, 2019 were $25.9 million compared to $23.2 million for the three months ended March 31, 2018 , an increase of $2.7 million , or 11.6% . The increase is primarily related to a reduction in selling, general and administrative expenses and the wind-down of our restructuring plan at our Malterdingen, Germany facility.

Interest Expense, Net

Interest expense, net for the three months ended March 31, 2019 was $9.5 million compared to $10.7 million for the three months ended March 31, 2018 , a decrease of $1.2 million , or 11.2% . The decrease are primarily due to a reduction in our weighted-average indebtedness as the Company made a total of $100.0 million in voluntary principal payments in 2018.

Loss on Debt Extinguishment

Loss on debt extinguishment was $0.3 million for the three months ended March 31, 2018 . The loss on debt extinguishment in 2018 relates to the write-off of deferred financing costs associated with the Company's incremental voluntary principal payments made on the 2017 Term Loan Facility.

Other Non-Operating Expense

Other non-operating expense was $0.2 million for the three months ended March 31, 2019 compared to $0.3 million for the three months ended March 31, 2018 . Other non-operating expense includes certain components of net periodic pension cost including interest costs, expected return on plan assets and amortization of actuarial gains and losses.

Income Tax Expense

Income tax expense for the three months ended March 31, 2019 was $7.0 million compared to $5.4 million for the three months ended March 31, 2018 , an increase of $1.6 million . Income tax expense for all periods was primarily due to earnings in jurisdictions paying cash taxes or where utilization of deferred tax assets was not offset by reversal of valuation allowances.

Loss from discontinued operations

Loss from discontinued operations for the three months ended March 31, 2019 was $10.0 million compared to $0.6 million for the three months ended March 31, 2018 , an increase of $9.4 million . The increase in the loss is primarily related to $8.5 million of expense to write down the net book value of one of the Company's manufacturing facilities in the Czech Republic which is classified as held for sale.

Non-GAAP Financial Measures

We prepare our financial statements in conformity with U.S. GAAP. To supplement this information, we also use the following non-GAAP financial measures: Adjusted EBITDA, Adjusted Net Income, Pro forma Net Sales and Pro forma New Orders. Because not all companies use identical calculations, these presentations may not be comparable to other similarly titled measures of other companies.

Adjusted EBITDA

Adjusted EBITDA represents net income before interest expense, taxes, depreciation and amortization, as further adjusted for the other items reflected in the reconciliation table set forth below. Adjusted EBITDA is a measure used by management to measure operating performance. Adjusted EBITDA is not a presentation made in accordance with U.S. GAAP, is not a measure of financial condition or profitability, and should not be considered as an alternative to net earnings (loss) determined in accordance with U.S. GAAP or operating cash flows determined in accordance with U.S. GAAP or any other performance measure derived in accordance with U.S. GAAP and should not be construed as an inference that our future results will be unaffected by unusual non-recurring items. Additionally, Adjusted EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not include certain cash requirements such as interest payments, tax payments, debt service requirements and certain other cash costs that may recur in the future.

We view Adjusted EBITDA as a key measure of our performance. We present Adjusted EBITDA not only due to its importance for purposes of our credit agreements but also because it assists us in comparing our performance across reporting periods on a consistent basis as it excludes items that we do not believe are indicative of our core operating performance. Our management uses Adjusted EBITDA:

• as a measurement used in evaluating our consolidated and segment-level operating performance on a consistent basis;

• to calculate incentive compensation for our employees;

• for planning purposes, including the preparation of our internal annual operating budget;

• to evaluate the performance and effectiveness of our operational strategies; and

• to assess compliance with various metrics associated with our debt agreements.

We believe that the inclusion of Adjusted EBITDA in this Quarterly Report on Form 10-Q is useful to provide additional information to investors about certain material non-cash items as well as items considered to be one-time or non-recurring to the operations of the business. While we believe these financial measures are commonly used by investors to evaluate our performance and that of our competitors, because not all companies use identical calculations, this presentation of Adjusted EBITDA may not be comparable to other similarly titled measures of other companies and should not be considered as an alternative to performance measures derived in accordance with U.S. GAAP. Adjusted EBITDA is calculated as net earnings (loss) before income tax expense, interest expense, net, depreciation and amortization further adjusted to exclude other items as reflected in the reconciliation table below.

In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses such as those used in calculating Adjusted EBITDA. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by usual or non-recurring items. Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementary.

Adjusted Net Income

Adjusted Net Income measures our operating performance by adjusting net earnings (loss) to exclude amortization expense, non-cash currency effect on intercompany advances, organizational redesign costs, long-term equity awards, acquisition integration costs, professional services and certain other non-recurring items. Management uses this measure to evaluate our core operating results as it excludes certain items whose fluctuations from period-to-period do not necessarily correspond to changes in the core operations of the business, but includes certain items such as depreciation, interest expense and income tax expense, which are otherwise excluded from Adjusted EBITDA. We believe the presentation of Adjusted Net Income enhances our investors’ overall understanding of the financial performance and cash flow of our business. You should not consider Adjusted Net Income as an alternative to net earnings (loss), determined in accordance with U.S. GAAP, as an indicator of operating performance.

Pro forma Net Sales

Pro forma Net Sales is defined as net sales excluding net sales directly attributable to certain product lines which have been discontinued or eliminated through plant closures. We present Pro forma Net Sales to facilitate comparisons of reported net sales from period to period. We believe the presentation of Pro forma Net Sales enhances our investors’ overall understanding of the financial performance of our business. You should not consider Pro forma Net Sales as an alternative to net sales, determined in accordance with U.S. GAAP, as an indicator of operating performance.

Pro forma New Orders

Pro forma New Orders is defined as new orders excluding orders directly attributable to certain product lines which have been discontinued or eliminated through plant closures. We present Pro forma New Orders to facilitate comparisons of reported new orders from period to period. We believe the presentation of Pro forma New Orders enhances our investors’ overall understanding of the financial performance of our business. You should not consider Pro forma New Orders as an alternative to new orders as an indicator of operating performance.

The following is a reconciliation of net earnings (loss), the most comparable U.S. GAAP measure, to Adjusted Net Income and to Adjusted EBITDA:



		Three Months Ended March 31,
		2019			2018
	(in millions)
Net (loss) earnings		$	(0.8	)	$	5.9
Loss from discontinued operations (net of income taxes)		10.0			0.6
Amortization expense		5.6			6.3
Currency effect on intercompany advances (a)		(1.6		)	0.5
Organizational redesign costs (b)		1.1			12.0
Long-term equity awards (c)		3.2			2.8
Debt costs		—			0.3
Professional services (d)		0.7			1.7
Tax adjustments (e)		0.9			(2.7		)
Other		—			0.5
Adjusted Net Income		19.1			27.9
Income tax expense (e)		6.1			8.1
Interest expense, net		9.5			10.7
Depreciation expense		6.3			6.9
Adjusted EBITDA		$	41.0		$	53.6


(a)	Non-cash currency effect on intercompany advances primarily relates to advances denominated in foreign currencies. The most significant exposure relates to the Canadian dollar and the Czech koruna pursuant to intercompany advances within the MDCS and Corporate segments, respectively.


(b)	Organizational redesign costs in the three months ended March 31, 2018 primarily included $8.1 million for termination costs as a result of eliminated positions.


(c)	Long-term equity awards include the charges associated with stock-based compensation awards granted to certain members of management and independent directors in the three months ended March 31, 2019 and 2018 .


(d)	Professional fees in the three months ended March 31, 2019 and 2018 included $0.7 million and $1.7 million , respectively, of costs for strategic organizational initiatives.

(e)

Tax adjustments primarily include the tax expense (benefit) associated with reconciling net (loss) earnings to Adjusted Net Income and reflects the impact to the quarterly tax provision utilizing the annual effective tax rate recomputed with anticipated tax rate reductions that have not been recognized for U.S. GAAP purposes as the Company is awaiting regulatory approval. The reductions have historically been approved although there are no guarantees that the regulatory authorities will accept the Company's applications.

The following table provides a reconciliation of operating earnings, the most comparable U.S. GAAP measure, to Adjusted EBITDA for each of our segments:



		Three Months Ended March 31,
		2019			2018
	(in millions)
Operating earnings (loss):
APPT		$	12.1		$	2.7
MDCS		18.4			26.7
Fluids		5.4			6.0
Corporate		(10.0		)	(12.2		)
Total operating earnings		25.9			23.2
Other non-operating expenses		(0.2		)	(0.3		)
Adjustments to operating earnings:
APPT Adjustments:
Depreciation and amortization		2.7			3.3
Organizational redesign costs (b)		0.1			9.9
Professional services (d)		—			0.1
Other		—			0.5
Total APPT Adjustments		2.8			13.8
MDCS Adjustments:
Depreciation and amortization		7.8			8.5
Currency effect on intercompany advances (a)		(1.0		)	1.7
Organizational redesign costs (b)		0.6			1.3
Total MDCS Adjustments		7.4			11.5
Fluids Adjustments:
Depreciation and amortization		1.0			1.1
Total Fluids Adjustments		1.0			1.1
Corporate Adjustments:
Depreciation and amortization		0.4			0.3
Currency effect on intercompany advances (a)		(0.6		)	(1.2		)
Organizational redesign costs (b)		0.4			0.8
Long-term equity awards (c)		3.2			2.8
Professional services (d)		0.7			1.6
Total Corporate Adjustments		4.1			4.3
Adjusted EBITDA:
APPT		14.7			16.2
MDCS		25.8			38.2
Fluids		6.4			7.1
Corporate		(5.9		)	(7.9		)
Total Adjusted EBITDA		$	41.0		$	53.6


(a)	Non-cash currency effect on intercompany advances primarily relates to advances denominated in foreign currencies. The most significant exposure relates to the Canadian dollar and the Czech koruna pursuant to intercompany advances within the MDCS and Corporate segments, respectively.


(b)	Organizational redesign costs in the three months ended March 31, 2018 included $7.9 million for termination costs as a result of eliminated positions in APPT.


(c)	Long-term equity awards in Corporate include the charges associated with stock-based compensation awards granted to certain members of management and independent directors during the three months ended March 31, 2019 and 2018 .


(d)	Professional fees incurred by Corporate in the three months ended March 31, 2019 and 2018 included $0.7 million and $1.6 million of costs for strategic organizational initiatives, respectively.

The following is a reconciliation of net sales, the most comparable U.S. GAAP measure, to Pro forma Net Sales:



	Three Months Ended March 31,
	2019			2018
	(in millions)
Net sales	$	248.7		$	288.8
Adjustments to net sales (a)	(0.6		)	(9.2		)
Pro forma Net Sales	$	248.1		$	279.6


(a)	Adjustments to net sales include net sales directly attributable to certain product lines which have been discontinued or eliminated through plant closures. Adjustments for the periods presented include our European Injection equipment and Systems businesses.

The following is a reconciliation of APPT net sales, the most comparable U.S. GAAP measure, to APPT Pro forma Net Sales:



	Three Months Ended March 31,
	2019			2018
	(in millions)
Net sales - APPT segment	$	119.4		$	140.3
Adjustments to net sales (a)	(0.6		)	(9.2		)
Pro forma Net Sales - APPT segment	$	118.8		$	131.1


(a)	Adjustments to net sales include net sales directly attributable to certain product lines which have been discontinued or eliminated through plant closures. Adjustments for the periods presented include our European Injection equipment and Systems businesses.

The following is a reconciliation of new orders, the most comparable U.S. GAAP measure, to Pro forma New Orders:



	Three Months Ended March 31,
	2019			2018
	(in millions)
New orders	$	275.3		$	308.5
Adjustments to new orders (a)	(1.5		)	(8.3		)
Pro forma New Orders	$	273.8		$	300.2


(a)	Adjustments to new orders include new orders directly attributable to certain product lines which have been discontinued or eliminated through plant closures. Adjustments for the periods presented include our European Injection equipment and Systems businesses.

Liquidity and Capital Resources

Our primary source of liquidity is cash generated from operations and availability under our senior secured asset-based revolving credit facility (the "ABL Facility") and other foreign credit facilities. At March 31, 2019 , we had cash and cash equivalents of $150.0 million , of which $19.0 million was held in the U.S. and $131.0 million was held by subsidiaries outside of the U.S. However, if such amounts were repatriated to the U.S., additional taxes would likely need to be accrued and paid depending on the source of the earnings remitted. For amounts we plan to repatriate, appropriate taxes have been accrued and we currently have no plans to repatriate any additional amounts for which U.S. taxes would need to be accrued.

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the "Tax Act") was signed into law and it institutes fundamental changes to the taxation of multinational corporations. The Tax Act reduces the corporate tax rate to 21%, repeals the alternative minimum tax, limits the interest deduction, enhances the expensing of capital investments, implements a dividend exemption system, eliminates the deferral of foreign earnings, provides a minimum tax on low-taxed foreign earnings and new measures to deter base erosion. The Company does not expect the Tax Act to have a material impact on our cash flows until existing U.S. net operating losses are utilized.

At March 31, 2019 , we had $62.1 million of availability under our ABL Facility and $16.0 million of availability under other credit facilities. Our primary cash requirements are for working capital, operating expenses, capital expenditures and scheduled payments of principal and interest. We may from time to time seek to retire our outstanding debt. Such events, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

During the three months ended March 31, 2019 , we used $34.0 million of cash compared to using $11.2 million in the three months ended March 31, 2018 . During the first three months of 2019 , cash was used primarily for capital expenditures, a $5.0 million voluntary payment on the 2017 Term Loan Facility as well as the purchase of treasury stock. During the first three months of 2018 , cash was used primarily for our $25.0 million voluntary principal payment on the 2017 Term Loan Facility.

We believe that our current level of operations, our cash and cash equivalents, cash flow from operations and availability under our ABL Facility and other foreign lines of credit will provide us adequate cash to fund the operating needs, working capital, capital expenditure, debt service and other requirements for our business for the foreseeable future. Our ability to make scheduled payments of principal or interest on, or to refinance, our indebtedness or to fund working capital requirements, capital expenditures and other current obligations will depend on our ability to generate cash from operations. Such cash generation is subject to general economic, financial, competitive and other factors that are beyond our control. We have unused availability, subject to certain terms and conditions and other limitations, of $78.1 million under these lines of credit.

The following table shows our statements of cash flows for the three months ended March 31, 2019 and 2018 :



	Three Months Ended March 31,
	2019			2018
	(in millions)
Statements of cash flow data
Net cash (used in) provided by operating activities from continuing operations	$	(4.6	)	$	11.7
Net cash (used in) provided by investing activities from continuing operations	(17.8		)	0.8
Net cash used in financing activities from continuing operations	(10.2		)	(22.3		)

Cash (used in) provided by operating activities from continuing operations

Operating activities from continuing operations for the three months ended March 31, 2019 used $4.6 million of cash compared to generating $11.7 million for the three months ended March 31, 2018 . The decrease was primarily driven by an increase in working capital.

Cash (used in) provided by investing activities from continuing operations

Investing activities from continuing operations for the three months ended March 31, 2019 used $17.8 million of cash compared to generating $0.8 million of cash for the three months ended March 31, 2018 . The decrease is due mainly to an increase in capital expenditures. Additionally, during the three months ended March 31, 2018 , the Company received proceeds of $8.0 million from the sale of certain manufacturing equipment in the Company's Advanced Plastic Processing Equipment segment which did not occur during the three months ended March 31, 2019 .

Cash used in financing activities from continuing operations

Financing activities from continuing operations for the three months ended March 31, 2019 used $10.2 million compared to using $22.3 million for the three months ended March 31, 2018 . During the three months ended March 31, 2019 , cash was primarily used for our $5.0 million voluntary principal payment on the 2017 Term Loan Facility as well as the purchase of treasury stock. During the three months ended March 31, 2018 , cash was primarily used for our $25.0 million voluntary principal payment on the 2017 Term Loan Facility. This use of cash was partially offset by proceeds generated from the exercise of stock options.

Total debt, excluding unamortized discount and debt issuance costs, was $835.6 million at March 31, 2019 compared to $843.6 million at December 31, 2018 . Total debt at March 31, 2019 mainly represented $832.5 million outstanding on the 2017 Term Loan Facility, while the ABL Facility was undrawn except for letter of credit issuances.

Description of the 2017 Term Loan Facility

On February 15, 2017, we entered into the $947.0 million 2017 Term Loan Facility, pursuant to a term loan agreement, among Milacron Holdings Corp., Milacron LLC, the guarantors party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent. The 2017 Term Loan Facility matures on September 28, 2023. The 2017 Term Loan Facility is secured by a first-priority lien on substantially all of the Company and guarantors’ assets other than accounts receivable, inventory, and other certain assets. The 2017 Term Loan Facility is also secured by a second-priority lien on all of the assets of the Company, Milacron LLC and the guarantors that secure the ABL Facility. The interest rate applicable to the 2017 Term Loan Facility is, at our option, equal to either (a) a base rate determined by the reference to the highest of (1) the prime commercial lending rate publicly announced by the administrative agent of the 2017 Term Loan Facility as the “prime rate” as in effect on such day, (2) the federal funds effective rate plus 0.50% , and (3) the LIBOR rate determined by reference to the cost of funds for Eurodollar deposits for an interest period of one month, plus 1.00% or (b) a LIBOR rate (which shall be no less than 0.00% ) determined by reference to the costs of funds for Eurodollar deposits for the specified interest period, as adjusted for certain statutory reserve requirements. The applicable margins for borrowings are (i) 2.00% with respect to base rate borrowings and 3.00% with respect to LIBOR borrowings, subject to compliance with a total net leverage ratio of greater than 3.50 to 1.00 and (ii) 1.75% with respect to base rate borrowings and 2.75% with respect to LIBOR borrowings, subject to compliance with a total net leverage ratio not to exceed 3.50 to 1.00 . The following amounts will be applied to repay the 2017 Term Loan Facility, subject to certain thresholds, carve-outs and exceptions: (i) 100% of the net cash proceeds of any incurrence of debt by us and certain of our subsidiaries, (ii) 100% of net cash proceeds of any non-ordinary course sale or other disposition of assets by us or certain subsidiaries and (iii) 50% of our excess cash flow, subject to certain reductions.

On November 8, 2017, the Company re-priced the 2017 Term Loan Facility. The applicable margins for borrowings are now (i) 1.75% with respect to base rate borrowings and 2.75% with respect to LIBOR borrowings, subject to compliance with a total net leverage ratio of greater than 3.50 to 1.00 and (ii) 1.50% with respect to base rate borrowings and 2.50% with respect to LIBOR borrowings, subject to compliance with a total net leverage ratio not to exceed 3.50 to 1.00. No other terms of the facility were changed.

Description of the ABL Facility

On April 30, 2012, we entered into the ABL Facility with Merrill Lynch, Pierce, Fenner & Smith Incorporated, RBC Capital Markets and Barclays Bank PLC, as joint lead arrangers and bookrunners which was amended and restated on March 28, 2013. The ABL Facility has a five-year term, bears interest at a floating rate and provides for an aggregate principal amount of $70.0 million of loans under the U.S. sub-facility thereunder and for an aggregate principal amount of $30.0 million of loans under the Canadian sub-facility thereunder, each subject to a borrowing base and other limitations. We have the right at any time to request up to $20.0 million of additional commitments. The existing lenders under the ABL Facility are not under any obligation to provide such additional commitments, and any increase in commitments is subject to customary conditions precedent. On March 17, 2014, we exercised our right to increase the U.S. sub-facility of the ABL Facility by $10.0 million to $80.0 million and decrease the Canadian sub-facility by $10.0 million to $20.0 million. The covenants and other terms of the ABL Facility were not changed. On October 17, 2014, the ABL Facility was amended and restated to add a $25.0 million German sub-facility and the term was reset to mature on February 14, 2019 or October 17, 2019 subject to the satisfaction of certain conditions on or prior to February 14, 2019. The covenants and other terms of the ABL Facility were not materially changed. On May 15, 2015, the credit agreement governing the ABL Facility was amended and restated to, among other things, conform certain terms to the credit agreement governing the New Term Loan Facility. On April 27, 2018, the ABL Facility was amended and restated to reduce each of the applicable margins in determining the interest rates on loans by 0.50% per annum, reduce the unused line fee by 0.125% per annum, extend the maturity date to April 27, 2023 and reallocate $5.0 million of availability under the ABL Facility from the German sub-facility to the U.S. sub-facility. The covenants and other terms of the ABL Facility were not significantly changed. We had approximately $32.0 million of letters of credit outstanding as of March 31, 2019 .

The obligations under the ABL Facility are secured, subject to certain exceptions, by substantially all of the assets of the borrowers and the assets of the guarantors under such facility. In addition, the ABL Facility includes certain customary negative covenants that, subject to exceptions, limit the ability of the borrowers and their restricted subsidiaries to incur additional indebtedness, pay dividends or certain other distributions on the Company’s capital stock, repurchase the Company’s capital stock, prepay subordinated indebtedness, incur liens on assets, make certain investments or other restricted payments, engage in transactions with affiliates, sell certain assets, merge or consolidate with or into other companies and alter the business that the Company conducts.

Description of Other Debt

At March 31, 2019 , we had $3.1 million of borrowings under certain lines of credit and discounting programs. We also had approximately $2.1 million of outstanding letters of credit and other commitments related to these facilities at March 31, 2019 .

Critical Accounting Policies and Estimates

We prepare our Condensed Consolidated Financial Statements in accordance with U.S. GAAP, and in doing so, we have to make estimates, assumptions and judgments affecting the reported amounts of assets, liabilities, revenue and expenses, as well as the related disclosure of contingent assets and liabilities. We base our estimates, assumptions and judgments on historical experience and on various other factors we believe to be reasonable under the circumstances. Different assumptions and judgments would change the estimates used in the preparation of our Condensed Consolidated Financial Statements, which, in turn, could change our results from those reported. We evaluate our critical accounting estimates, assumptions and judgments on an ongoing basis.

There have been no material changes in our critical accounting policies from those previously included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on February 28, 2019.

Recently Issued Accounting Pronouncements

For information on recent accounting pronouncements, see Note 1 to the Company's Condensed Consolidated Financial Statements appearing in Part I, Item 1. of this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market Risk

We are exposed to financial market risks associated with foreign currency exchange rates, interest rates, commodity prices and credit risk. In the normal course of business and in accordance with our policies, we manage these risks through a variety of strategies, which may include the use of derivative financial instruments to hedge our underlying exposure. We do not use derivative instruments for speculative or trading purposes and we have policies and procedures in place that monitor and control their use.

Foreign Currency Exchange Rate Risk

We operate in international markets and, accordingly, our competitiveness and financial results are subject to foreign currency fluctuations where revenues and costs are denominated in currencies other than the U.S. dollar. In fiscal 2018 and during the three months ended March 31, 2019 , approximately 59% of our sales from continuing operations were attributable to our operations outside of the United States. Approximately 54% of sales in fiscal 2018 were denominated in currencies other than the U.S. dollar, whereas a significant portion of our fixed costs, including payments made on our ABL Facility and our 2017 Term Loan Facility are denominated in U.S. dollars. Our earnings could be materially impacted particularly by movement in the exchange rate between the Canadian dollar, the Euro, the Chinese yuan renminbi, the Indian rupee and the U.S. dollar.

We occasionally use foreign currency forward exchange contracts to hedge our exposure to adverse changes in foreign currency exchange rates related to known or expected cash flow exposures arising from international transactions. At March 31, 2019 and December 31, 2018 , we had $37.6 million and $6.5 million, respectively, notional amount of forward exchange contracts outstanding with remaining maturities of up to nine months. As of March 31, 2019 , the net fair value asset of financial instruments with exposure to foreign currency risk was $0.2 million. As of December 31, 2018 , the net fair value asset of financial instruments with exposure to foreign currency risk was $0.3 million. The fair value of these financial instruments would hypothetically decrease by $4.0 million and $0.4 million as of March 31, 2019 and December 31, 2018 , respectively, if the U.S. dollar were to appreciate against all other currencies by 10% of current levels.

Our investments and loans to our foreign operations create additional foreign currency exposure. In November 2018, we entered into a cross-currency interest rate swap agreement that will mature on September 28, 2023, with an aggregate notional amount of $85.8 million to manage foreign currency risk by effectively converting a portion of the Company's variable rate U.S. dollar-denominated debt, including the monthly interest rates thereunder, to fixed rate Euro-denominated debt of €75.0 million. This cross-currency interest rate swap agreement is designated as a hedge of a portion of our net investment in Euro-denominated foreign operations to reduce foreign currency risk associated with the investment in these operations. In addition to managing foreign currency exchange rate risk, the interest rate swap component of this transaction also manages interest rate risk for the Company by fixing the interest rate on a portion of the Company's debt outstanding under the 2017 Term Loan Facility that was previously subject to a floating interest rate equal to 1-month LIBOR plus a credit spread. The interest rate swap provides for the Company to pay a fixed rate of 0.05% plus the loan spread for the term and debt hedged. Changes in the value of these items resulting from fluctuations in the underlying exchange rates to U.S. dollar exchange rates are recorded as foreign currency translation adjustments within accumulated other comprehensive income (loss).

Interest Rate Risk

We are primarily exposed to interest rate risk through our ABL Facility, 2017 Term Loan Facility and other foreign lines of credit. Interest on our ABL Facility accrues, at our option, at either (i) LIBOR plus a margin of 1.25% to 1.75% per annum, based on availability or (ii) the highest rate of (a) the prime rate, (b) the federal funds rate plus 0.50% per annum, or (c) LIBOR plus 1.00% per annum, plus a margin of 0.25% to 0.75% per annum, based on availability. Interest on the 2017 Term Loan Facility accrues, at our option, equal to either (i) the published LIBOR rate, plus a margin of 2.50% (if our total net leverage ratio is less than or equal to 3.50 to 1.00) or 2.75% (if our total net leverage ratio is greater than 3.50 to 1.00) per annum or (ii) the greater of (1) the prime rate, (2) the federal funds rate plus 0.50% per annum, (3) published LIBOR rate plus 1.00% or (4) 2.00% per annum, plus 1.50% (if our total net leverage ratio is less than or equal to 3.50 to 1.00) or 1.75% (if our total net leverage ratio is greater than 3.50 to 1.00) per annum. In no event will the LIBOR rate be less than 0.00% at any time. We currently estimate that our annual interest expense on floating rate indebtedness would increase by approximately $3.5 million for each 1.00% increase in interest rates.

In order to manage this risk, on February 16, 2017, Milacron LLC, a wholly-owned subsidiary of the Company, entered into two interest rate swap transactions effective for a period of four years beginning January 31, 2018 with a total notional amount of $400.0 million . The interest rate swaps are intended to manage the Company's interest rate risk by fixing the interest rate on a portion of the Company's debt outstanding under the 2017 Term Loan Facility that was previously subject to a floating interest rate equal to 1-month LIBOR plus a credit spread. The swaps provide for the Company to pay a fixed rate of 2.062% per annum on such portion of the outstanding debt in exchange for receiving a variable interest rate based on 1-month LIBOR. The effect is a synthetically fixed rate of 2.062% plus the loan spread for the term and debt hedged.

In July 2017, the Financial Conduct Authority (the authority that regulates LIBOR) announced it intends to stop compelling banks to submit rates for the calculation of LIBOR after 2021. The Alternative Reference Rates Committee ("ARRC") has proposed that the Secured Overnight Financing Rate ("SOFR") is the rate that represents best practice as the alternative to USD-LIBOR for use in derivatives and other financial contracts that are currently indexed to USD-LIBOR. ARRC has proposed a paced market transition plan to SOFR from USD-LIBOR and organizations are currently working on industry wide and company specific transition plans as it relates to derivatives and cash markets exposed to USD-LIBOR. The Company has material contracts that are indexed to USD-LIBOR and is monitoring this activity and evaluating the related risks.

Commodity Risk

We have direct and indirect exposure to certain commodities, principally steel and steel-based components. We typically do not enter into derivative financial instruments to hedge our commodity price risk and we do not currently have long-term supply contracts with key suppliers. While future movements of steel costs are uncertain, we respond to this volatility in a number of ways, including strategic steel purchases and customer price adjustments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Management, with the participation of our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our CEO and CFO concluded that, as of March 31, 2019 , our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

Except as set forth below, during the quarter ended March 31, 2019 , we did not make any changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

During the quarter ended March 31, 2019, we implemented a new lease accounting system and process in response to the adoption of ASU No. 2016-02, Leases (Topic 842) , effective January 1, 2019. These implementations resulted in a material change in a component of our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Various lawsuits arising during the normal course of business are pending against us and our consolidated subsidiaries. We are vigorously defending these claims and believe we have reserves and insurance coverage sufficient to cover potential exposures.

While, in the opinion of management, the liability resulting from these matters will not have a significant effect on our consolidated financial position, results of operations or liquidity, the outcome of individual matters cannot be predicted with reasonable certainty at this time.

ITEM 1A. RISK FACTORS

For a discussion of our potential risks and uncertainties, see the information in Item 1A. Risk Factors of the Company's Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on February 28, 2019.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no unregistered sales of equity securities during the first quarter of 2019 or from March 31, 2019 through the date of filing this Quarterly Report on Form 10-Q.

Issuer Purchases of Equity Securities

In November 2018, we announced that our Board of Directors approved a share repurchase program, under which we may repurchase up to an aggregate amount of $125.0 million of our outstanding equity securities over a two-year period. The timing of share purchases pursuant to the program is dependent upon certain factors, including but not limited to, market conditions and prices, available funds and alternative uses of capital. The repurchase program may be carried out through open-market purchases, block trades, negotiated private transactions and pursuant to a trading plan adopted in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

The Company's share repurchase activity for each of the three months in the quarter ended March 31, 2019, was as follows:



Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
	(in millions, except share and per share data)
January 2019	75,126	$	13.29	75,126
February 2019	134,903	$	14.06	134,903
March 2019	60,183	$	13.27	60,183
Total	270,212	$	13.69	270,212	$	117.8

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

ITEM 6. EXHIBITS

The following is an index of the exhibits included in this report:



Exhibit Number:

10.1*	Employment Agreement, dated as of January 1, 2013, between Mold-Masters (2007) Limited and Ling An-Heid.
10.2*	Employment Contract for Managing Director, dated as of June 1, 2003, between Cimcool Industrial Products B.V. and Gerrit Jue.
10.3*	Assignment Agreement, dated as of September 22, 2016, between Cimcool Industrial Products B.V., Milacron LLC and Gerrit Jue.
10.4*	Severance Agreement, dated as of February 1, 2019, between Milacron Holdings Corp. and Mark Miller.
31.1	Certification of Chief Executive Officer, pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2012.
31.2	Certification of Chief Financial Officer, pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2012.
32.1**	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.0	The following materials from Milacron Holdings Corp.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) the Condensed Consolidated Statements of Cash Flows, and (v) the Notes to the Condensed Consolidated Financial Statements.

*Filed herewith pursuant to Item 601(b)(10)(iii)(a) of Regulation S-K. Ms. An-Heid and Messrs. Jue and Miller became named executive officers during the reporting period covered by this Quarterly Report on Form 10-Q.
**The certifications attached as Exhibit 32.1 accompanying this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.





	Milacron Holdings Corp.

Date: May 2, 2019	By:	/s/ BRUCE CHALMERS
		Bruce Chalmers
		Chief Financial Officer



/s/ Susan Malcolmson		MOLD-MASTERS (2007) LIMITED

Susan Malcolmson		/s/ Connie Bender
		Name: Connie Bender
Witness: Signature, Name and Address		Title: VP Global Human Resources



/s/ Connie Bender		/s/ Ling An-Heid

Connie Bender		Ling An-Heid

Witness: Signature, Name and Address



2 .	Severance Benefit s .
(a)	Termination for Ca u se; R esig n a ti o n Without Good R easo n .	If the





Date: May 2, 2019	By:	/s/ THOMAS GOEKE
		Thomas Goeke
		President and Chief Executive Officer


1.1	The parties agree that the recital clauses outlined above are true and correct and form a part of this Employment Agreement.


2.1	The Company agrees to employ the Employee to perform, and the Employee agrees and undertakes to perform, the duties and responsibilities of President, Mold-Masters Asia, and such other duties and responsibilities as may be requested of the Employee by the Company from time to time.


2.2	The Employee understands and agrees that the Company may reduce, expand or otherwise modify the Employee's duties and responsibilities, as necessary, during the employment relationship between the Employee and the Company.


2.5	The Employee undertakes and agrees to abide by all of the Company's rules, practices and procedures set forth in the Company's Employee Handbook, as amended from time to time, a copy of which will be made available to the Employee online. Further, the Employee acknowledges and agrees that it is the Employee's duty to review the same and be familiar therewith.


3.1	The Parties agree that this Employment Agreement shall be effective as of and from the January 1 ^st , 2013, which date shall be referred to as the "Effective Date" of this Employment Agreement.


7.1	The Parties understand and agree that the Employee's employment pursuant to this Employment Agreement, may be terminated in the applicable manner, and in the circumstances, specified below:


b)	by the Company, at any time, in its sole discretion, without any notice or pay in lieu thereof, for cause. For the purposes of this Employment Agreement, "cause" includes, without limitation, the following:


vi)	a false statement on either the Employee's resume or employment application;


vii)	any material breach of the provisions of this Employment Agreement by the


viii)	any willful or reckless violation of an established company rule contained in the Company's Employee Handbook, or, of which the Employee has been otherwise apprised;


x)	any other act, omission or circumstance recognized by law as cause for termination.


c)	subject to Article 7.4 and subject to Article 7.7 by the Company, at any time in its absolute discretion and for any reason other than for cause, upon providing the Employee with:


i)	all payments or entitlements to which the Employee is entitled pursuant to the Ontario Employment Standards Act, 2000 as amended, including notice of termination or, at the Company's option, pay in lieu of notice, and severance pay, if applicable. Severance pay will be calculated using the employee's current base salary, only, and will not include additional payments made to the employee.


7.2	All payments contemplated under this Article 7 will be calculated on the basis of the Employee's annual base salary as of the date the Employee receives notice of termination. Payments under a bonus plan or any other forms of additional compensation will not be considered part of the annual base salary.


7.6	Upon the termination of this Employment Agreement, however caused, the Employee further agrees to provide all reasonable assistance and cooperation to the Company in order to assist the Company to obtain access to, possession and control of, all Company property, in the Employee's possession or under the Employee's control.


b)	induce or attempt to persuade any person providing employment, consulting, marketing or other services to the Company to not provide, or to cease to provide, such services to the Company;


c)	solicit for employment, employ or otherwise retain Employees of the Company (other than Employees who have ceased to be employed by the other Party prior to the date of the solicitation); or,


d)	engage in any act or activity which would interfere with or harm any business relationship the Company may have with any investor, customer, employee, principal or supplier.


8.8	Notwithstanding any other provision of this Employment Agreement this Article 8 shall survive the termination of this Employment Agreement, however caused.


9.1	In this Employment Agreement the term "Works" shall mean and include: (i) any inventions, trade secrets, ideas, original works of authorship or any other form of intellectual property that the Employee conceives, develops, discovers or makes in whole or in part during the Employee's employment or engagement by the Company which relate to the Company's business or the


9.3	The Employee shall have no right to exercise any economic rights to the Works. Without limiting the foregoing, the Employee will not have the right to and will not reproduce, adapt, modify, publish, distribute, sublicense, publicly perform or communicate, translate, lease, import or otherwise exploit the Works, except as expressly authorized by the Company.


9.4	The Employee expressly acknowledges and agrees that the Employee wishes to remain anonymous and not to have the Employee's name or any pseudonym used in connection with the Works.


9.5	The Employee hereby waives in whole any moral rights the Employee may have with respect to the Works, including but not limited to the right to the integrity of the Works, the right to be associated with the Works as its author by name or under a pseudonym and the right to remain anonymous.


9.8	The Company shall have the unrestricted right to transfer and convey any or all of the Company's rights in or relating to the Works to any person or entity.


9.13	Notwithstanding any other provision of this Employment Agreement this Article 9 shall survive the termination of this Employment Agreement, however caused.


10.1	The Employee understands and consents that the Company may collect use or disclose personal information about the Employee as required for those purposes necessary for the conduct and administration of the employment relationship and pensions and benefits administration ("Employee Personal Information"). Examples of these purposes include, but are not limited to:


◦	provision of references to potential employers, financial institutions, or educational establishments;


◦	performance development reviews and other performance assessments, appraisals, etc.; and


◦	photographs used for identification cards, management reports or associate announcements.


10.2	The Employee understands and agrees that the Company may disclose the Employee's Personal Information to a third party or administrator, for the purpose of administering the Employee's employment relationship with the Company and consents to such disclosure.